Dose-dependent osteogenic effect of octacalcium phosphate on mouse bone marrow stromal cells

Tissue Engineering - Part A.

Volumn 14, Issue 6, 2008, Pages 965-978

  Anada, Takahisa ^a   Kumagai, Takashi ^a   Honda, Yoshitomo ^a   Masuda, Taisuke ^a   Kamijo, Ryutaro ^b   Kamakura, Shinji ^c   Yoshihara, Nobuhito ^a   Kuriyagawa, Tsunemoto ^a   Shimauchi, Hidetoshi ^a   Suzuki, Osamu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CALCIUM; CELL CULTURE; CELLS; CLADDING (COATING); COATINGS; CRYSTALLOGRAPHY; CRYSTALS; HYDROXYAPATITE; HYDROXYLATION; PHOSPHATE MINERALS; POWDERS; SOLIDS; STRUCTURAL PROPERTIES; THIN FILMS; TISSUE; TISSUE CULTURE;

(PL) PROPERTIES; BIOLOGICAL APATITES; BONE DEFECTS; BONE MARROW (BM); BONE REGENERATION; BONE-MARROW STROMAL CELL (BMSC); CELL LINES; CONCENTRATION (COMPOSITION); DOSE DEPENDENT; HYDROXYAPATITE (HAP); OCTACALCIUM PHOSPHATE (OCP); OCTACALCIUM PHOSPHATES (OCP) COATINGS; OSTEOGENIC PHENOTYPE; PHYSICO-CHEMICAL PROPERTIES; SUPERNATANTS; TISSUE CULTURE PLATES;

OPEN CIRCUIT VOLTAGE;

ALKALINE PHOSPHATASE; APACERAM; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; HYDROXYAPATITE; LACTATE DEHYDROGENASE; PHOSPHATE; TRANSCRIPTION FACTOR OSTERIX;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

EID: 45549107026     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0339     Document Type: Article

References (58)

1. Brown, W.E., Smith, J.P., Lehr, J.R., and Frazier, A.W. Crystallographic and chemical relations between octacalcium phosphate and hydroxyapatite. Nature 196, 1050, 1962.
2. Grynpas, M.D., and Omelon, S. Transient precursor strategy or very small biological apatite crystals? Bone 41, 162, 2007.
3. Tohda, H., Yamada, M., Yamaguchi, Y., and Yanagisawa, T. High-resolution electron microscopical observations of initial enamel crystals. J Electron Microsc 46, 97, 1997.
4. Bodier-Houlle, P., Steuer, P., Voegel, J.C., and Cuisinier, F.J. First experimental evidence for human dentine crystal formation involving conversion of octacalcium phosphate to hydroxyapatite. Acta Crystallogr D Biol Crystallogr 54, 1377, 1998.
5. Crane, N.J., Popescu, V., Morris, M.D., Steenhuis, P., and Ignelzi, M.A. Raman spectroscopic evidence for octacalcium phosphate and other transient mineral species deposited during intramembranous mineralization. Bone 39, 434, 2006.
6. LeGeros, R.Z., Daculsi, G., Orly, I.A., Abergas, T., and Torres, W. Solution-mediated transformation of octacalcium phosphate (OCP) to apatite. Scanning Microsc 3, 129, 1989.
7. Tomazic, B.B., Tung, M.S., Gregory, T.M., and Brown, W.E. Mechanism of hydrolysis of octacalcium phosphate. Scanning Microsc 3, 119, 1989.
8. Tseng, Y.H., Mou, C.Y., and Chan, J.C. Solid-state NMR study of the transformation of octacalcium phosphate to hydroxyapatite: a mechanistic model for central dark line formation. J Am Chem Soc 128, 6909, 2006.
9. Tung, M.S., Tomazic, B., and Brown, W.E. The effects of magnesium and fluoride on the hydrolysis of octacalcium phosphate. Arch Oral Biol 37, 585, 1992.
10. Brown, W.E., Mathew, M., and Tung, M.S. Crystal chemistry of octacalcium phosphate. Prog Cryst Growth Charact 4, 59, 1981.
11. Suzuki, O., Kamakura, S., and Katagiri, T. Surface chemistry and biological responses to synthetic octacalcium phosphate. J Biomed Mater Res Appl Biomater 77B, 201, 2006.
12. Suzuki, O., Yagishita, H., Amano, T., and Aoba, T. Reversible structural changes of octacalcium phosphate and labile acid phosphate. J Dent Res 74, 1764, 1995.
13. Barrere, F., van der Valk, C.M., Dalmeijer, R.A., Meijer, G., van Blitterswijk, C.A., de Groot, K., and Layrolle, P. Osteogenecity of octacalcium phosphate coatings applied on porous metal implants. J Biomed Mater Res A 66, 779, 2003.
14. Barrere, F., van der Valk, C.M., Dalmeijer, R.A., van Blitterswijk, C.A., de Groot, K., and Layrolle, P. In vitro and in vivo degradation of biomimetic octacalcium phosphate and carbonate apatite coatings on titanium implants. J Biomed Mater Res A 64, 378, 2003.
15. Bigi, A., Bracci, B., Cuisinier, F., Elkaim, R., Fini, M., Mayer, I., Mihailescu, I.N., Socol, G., Sturba, L., and Torricelli, P. Human osteoblast response to pulsed laser deposited calcium phosphate coatings. Biomaterials 26, 2381, 2005.
16. Dekker, R.J., de Bruijn, J.D., Stigter, M., Barrere, F., Layrolle, P., and van Blitterswijk, C.A. Bone tissue engineering on amorphous carbonated apatite and crystalline octacalcium phosphate-coated titanium discs. Biomaterials 26, 5231, 2005.
17. Habibovic, P., Li, J., van der Valk, C.M., Meijer, G., Layrolle, P., van Blitterswijk, C.A., and de Groot, K. Biological performance of uncoated and octacalcium phosphate-coated Ti6Al4V. Biomaterials 26, 23, 2005.
18. Kamakura, S., Sasano, Y., Shimizu, T., Hatori, K., Suzuki, O., Kagayama, M., and Motegi, K. Implanted octacalcium phosphate is more resorbable than beta-tricalcium phosphate and hydroxyapatite. J Biomed Mater Res 59, 29, 2002.
19. Suzuki, O., Nakamura, M., Miyasaka, Y., Kagayama, M., and Sakurai, M. Bone formation on synthetic precursors of hydroxyapatite. Tohoku J Exp Med 164, 37, 1991.
20. Imaizumi, H., Sakurai, M., Kashimoto, O., Kikawa, T., and Suzuki, O. Comparative study on osteoconductivity by synthetic octacalcium phosphate and sintered hydroxyapatite in rabbit bone marrow. Calcif Tissue Int 78, 45, 2006.
21. Suzuki, O., Kamakura, S., Katagiri, T., Nakamura, M., Zhao, B., Honda, Y., and Kamijo, R. Bone formation enhanced implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27, 2671, 2006.
22. Liu, Y., Cooper, P.R., Barralet, J.E., and Shelton, R.M. Influence of calcium phosphate crystal assemblies on the proliferation and osteogenic gene expression of rat bone marrow stromal cells. Biomaterials 28, 1393, 2007.
23. Shelton, R.M., Liu, Y., Cooper, P.R., Gbureck, U., German, M.J., and Barralet, J.E. Bone marrow cell gene expression and tissue construct assembly using octacalcium phosphate microscaffolds. Biomaterials 27, 2874, 2006.
24. Suzuki, O., Nakamura, M., Miyasaka, Y., Kagayama, M., and Sakurai, M. Maclura pomifera agglutinin-binding glycoconjugates on converted apatite from synthetic octacalcium phosphate implanted into subperiosteal region of mouse calvaria. Bone Miner 20, 151, 1993.
25. Kokubo, T. Bioactive glass ceramics: properties and applications. Biomaterials 12, 155, 1991.
26. Otsuka, E., Yamaguchi, A., Hirose, S., and Hagiwara, H. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol Cell Physiol 277, 132, 1999.
27. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T.J., and Suda, T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87, 7260, 1990.
28. Koike, M., Shimokawa, H., Kanno, Z., Ohya, K., and Soma, K. Effects of mechanical strain on proliferation and differentiation of bone marrow stromal cell line ST2. J Bone Miner Metab 23, 219, 2005.
29. LeGeros, R.Z. Preparation of octacalcium phosphate (OCP): a direct fast method. Calcif Tissue Int 37, 194, 1985.
30. Cordewener, F.W., van Geffen, M.F., Joziasse, C.A.P., Schmitz, J.P., Bos, R.R.M., Rozema, F.R., and Pennings, A.J. Cytotoxicity of poly(96L/4D-lactide): the influence of degradation and sterilization. Biomaterials 21, 2433, 2000.
31. Suzuki, O., Yagishita, H., Yamazaki, M., and Aoba, T. Adsorption of bovine serum albumin onto octacalcium phosphate and its hydrolyzates. Cells Mater 5, 45, 1995.
32. Okumura, M., Ohgushi, H., Dohi, Y., Katuda, T., Tamai, S., Koerten, H.K., and Tabata, S. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 37, 122, 1997.
33. Fimi, M., Giardino, R., Borsari, V., Torricelli, P., Rimondini, R., Giavaresi, G., and Nicoli, A.N. In vitro behaviour of osteoblasts cultured on orthopaedic biomaterials with different roughness, uncoated and fluorohydroxyapatite-coated, relative to the in vivo osteointegration rate. Int J Artif Organs 26, 520, 2003.
34. Kim, M.J., Kim, C.W., Lim, Y.J., and Heo, S.J. Microrough titanium surface affects biologic response in MG63 osteoblast-like cells. J Biomed Mater Res 79A, 1023, 2006.
35. Martin, J.Y., Schwartz, Z., Hummert, T.W., Schraub, D.M., Simpson, J., Lankford, J., Jr., Dean, D.D., Cochran, D.L., and Boyan, B.D. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 29, 389, 1995.
36. Borsari, V., Giavaresi, G., Fimi, M., Torricelli, P., Tschon, M., Chiesa, R., Chiusoli, L., Salito, A., Volpert, A., and Giardino, R. Comparative in vitro study on a ultra-high roughness and dense titanium coating. Biomaterials 26, 4948, 2005.
37. Deligianni, D.D., Katsala, N.D., Koutsoukos, P.G., and Missirlis, Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 22, 87, 2001.
38. Fujimori, S. Surface characterization of titanium plates with different surface treatments and cellular proliferation and expression of osteoblast-like cells in vitro on their surface. J Dent Mater 14, 155, 1995.
39. Ruoslahti, E., and Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins. Science 238, 491, 1987.
40. Takeichi, M. Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol 75, 464, 1977.
41. Dvorak, M.M., Siddiqua, A., Ward, D.T., Carter, D.H., Dallas, S.L., Nemeth, E.F., and Riccardi, D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101, 5140, 2004.
42. Aoba, T., and Moreno, E.C. Preparation of hydroxyapatite crystals and their behavior as seeds for crystal growth. J Dent Res 63, 874, 1984.
43. Bellows, C.G., Heersche, J.N., and Aubin, J.E. Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner 17, 15, 1992.
44. Meleti, Z., Shapiro, I.M., and Adams, C.S. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone 27, 359, 2000.
45. Stein, G.S., and Lian, J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14, 424, 1993.
46. Lynch, M.P., Stein, J.L., Stein, G.S., and Lian, J.B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216, 35, 1995.
47. Murshed, M., Harmey, D., Millan, J.L., McKee, M.D., and Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19, 1093, 2005.
48. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
49. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
50. Otto, F., Thornell, A.P., Cromptom, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P.B., and Owen, M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblastic differentiation and bone development. Cell 89, 765, 1997.
51. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., and de Crombrugghe, B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17, 2002.
52. Tai, G., Christodoulou, I., Bishop, A.E., and Polak, J.M. Use of green fluorescent fusion protein to track activation of the transcription factor osterix during early osteoblast differentiation. Biochem Biophys Res Commun 333, 1116, 2005.
53. Stein, G.S., Lian, J.B., Stein, J.L., van Wijnen, A.J., and Montecino, M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76, 593, 1996.
54. Torii, Y., Hitomi, K., Yamagishi, Y., and Tsukagoshi, N. Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biol Int 20, 459, 1996.
55. Beck, G.R., Zerler, B., and Moran, E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 97, 8352, 2000.
56. Beck, G.R., and Knecht, N. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278, 41921, 2003.
57. Lee, W.K., Ko, J.S., and Kim, H.M. Effect of electrostatic interaction on the adsorption of globular proteins on octacalcium phosphate crystal film. J Colloid Interface Sci 246, 70, 2002.
58. Kamakura, S., Nakajo, S., Suzuki, O., and Sasano, Y. New scaffold for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 71A, 299, 2004.